Debra L Foley1, Andrew Mackinnon2,3, Vera A Morgan4, David J Castle5, Anna Waterreus4, Cherrie A Galletly6,7,8. 1. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia. 2. Black Dog Institute, University of New South Wales, Sydney, Australia. 3. Centre for Mental Health, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia. 4. Neuropsychiatric Epidemiology Research unit, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia. 5. St Vincent's Hospital, Melbourne & Department of Psychiatry, University of Melbourne, Melbourne, Australia. 6. Discipline of Psychiatry, University of Adelaide, Adelaide, Australia. 7. Ramsay Health Care (SA) Mental Health, Adelaide, Australia. 8. Northern Adelaide Local Health Network SA, Adelaide, Australia.
Abstract
Objective: People with psychosis have an elevated risk of depression and diabetes but no large-scale study has characterized their relationship. We aimed to assess this association and to evaluate possible explanatory factors. Methods: Analysis of cross-sectional data from a national sample of 1155 people with psychosis who gave a fasting blood sample and could be tested for diabetes mellitus. The association between current diabetes mellitus and current depression was estimated using logistic regression, adjusted for age, sex and current psychotropic medication. Results: A diagnosis of depression was significantly associated with diabetes (OR = 2.16, P = .048) and diabetes medication (OR = 2.50, P = .050) in people with schizophrenia but no other psychosis subtype. Adjustment for cognitive processing speed and current residence (especially psychiatric hospitalization) attenuated that association to nonsignificance. Diabetes and diabetes medication were not significantly associated with antidepressant or mood stabilizer medication. Conclusions: Clinicians should be aware that people with schizophrenia and diabetes have twice the rate of current depression, and that comorbid diabetes and depression is associated with cognitive impairment and hospitalization. Efforts to disentangle the causal pathways between diabetes, depression, and cognition in people with schizophrenia may be complicated by multiple indications in people with psychosis for the prescription of depression medication, and their lack of association with diabetes mellitus.
Objective: People with psychosis have an elevated risk of depression and diabetes but no large-scale study has characterized their relationship. We aimed to assess this association and to evaluate possible explanatory factors. Methods: Analysis of cross-sectional data from a national sample of 1155 people with psychosis who gave a fasting blood sample and could be tested for diabetes mellitus. The association between current diabetes mellitus and current depression was estimated using logistic regression, adjusted for age, sex and current psychotropic medication. Results: A diagnosis of depression was significantly associated with diabetes (OR = 2.16, P = .048) and diabetes medication (OR = 2.50, P = .050) in people with schizophrenia but no other psychosis subtype. Adjustment for cognitive processing speed and current residence (especially psychiatric hospitalization) attenuated that association to nonsignificance. Diabetes and diabetes medication were not significantly associated with antidepressant or mood stabilizer medication. Conclusions: Clinicians should be aware that people with schizophrenia and diabetes have twice the rate of current depression, and that comorbid diabetes and depression is associated with cognitive impairment and hospitalization. Efforts to disentangle the causal pathways between diabetes, depression, and cognition in people with schizophrenia may be complicated by multiple indications in people with psychosis for the prescription of depression medication, and their lack of association with diabetes mellitus.
Authors: D J Castle; A Jablensky; J J McGrath; V Carr; V Morgan; A Waterreus; G Valuri; H Stain; P McGuffin; A Farmer Journal: Psychol Med Date: 2005-09-29 Impact factor: 7.723
Authors: Aaron A Lee; Christine L McKibbin; Katelynn A Bourassa; Thomas L Wykes; Katherine A Kitchen Andren Journal: Psychosomatics Date: 2013-12-31 Impact factor: 2.386
Authors: Vera A Morgan; Anna Waterreus; Assen Jablensky; Andrew Mackinnon; John J McGrath; Vaughan Carr; Robert Bush; David Castle; Martin Cohen; Carol Harvey; Cherrie Galletly; Helen J Stain; Amanda L Neil; Patrick McGorry; Barbara Hocking; Sonal Shah; Suzy Saw Journal: Aust N Z J Psychiatry Date: 2012-06-13 Impact factor: 5.744
Authors: David W Dunstan; Paul Z Zimmet; Timothy A Welborn; Maximilian P De Courten; Adrian J Cameron; Richard A Sicree; Terry Dwyer; Stephen Colagiuri; Damien Jolley; Matthew Knuiman; Robert Atkins; Jonathan E Shaw Journal: Diabetes Care Date: 2002-05 Impact factor: 19.112
Authors: Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs Journal: J Int Neuropsychol Soc Date: 2014-02-20 Impact factor: 2.892
Authors: V A Morgan; J J McGrath; A Jablensky; J C Badcock; A Waterreus; R Bush; V Carr; D Castle; M Cohen; C Galletly; C Harvey; B Hocking; P McGorry; A L Neil; S Saw; S Shah; H J Stain; A Mackinnon Journal: Psychol Med Date: 2013-12-23 Impact factor: 7.723